Neurofibromatosis-related tumors: emerging biology and therapies.
about
Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research.Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.Emerging genotype-phenotype relationships in patients with large NF1 deletions.CNS Tumors in Neurofibromatosis.Immortalization of human normal and NF1 neurofibroma Schwann cells.The NF1 gene in tumor syndromes and melanoma.Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods.Prospect and progress of oncolytic viruses for treating peripheral nerve sheath tumors.Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cellsReduced RAC1 activity inhibits cell proliferation and induces apoptosis in neurofibromatosis type 2(NF2)-associated schwannoma.Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors.LiCl Treatment Induces Programmed Cell Death of Schwannoma Cells through AKT- and MTOR-Mediated Necroptosis.Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas
P2860
Q33902151-4288550E-351F-46E4-9130-23A30569A689Q37640687-6C724C56-0AF0-4BE2-B347-54E11CFA3B84Q37725901-2D8C079E-12D4-4B26-8369-ED4352AEDE74Q38713914-D73129A2-F7C6-4F28-8C0F-4C76C044E239Q38746881-8E7F5FD0-B298-454B-96FF-61930C8672C0Q39076849-271BB709-CE4D-4DF3-9C82-807384E3B592Q39081518-1C63F798-0600-4504-A859-1A204B6F8FFDQ40465319-CDFC595B-D600-4347-B75D-1ACFC6672324Q42223215-1300F1A7-0927-4495-B736-C487A8C1DCA1Q49959424-AC9DDBEA-43EC-43C5-916F-858B5AA9C3FDQ50089792-F709EE14-9F28-40C3-9649-33280683FD08Q51064099-E07BE14A-D041-4650-92C5-925EF3486C6EQ52606710-6555E787-17BE-4B1A-B63B-7E84032BDA3DQ52657766-471EA79C-CAEC-42D9-83A9-A6F82FAC3B01Q58699185-813CC7E0-28EB-410F-B74C-469795FE62DE
P2860
Neurofibromatosis-related tumors: emerging biology and therapies.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Neurofibromatosis-related tumors: emerging biology and therapies.
@ast
Neurofibromatosis-related tumors: emerging biology and therapies.
@en
type
label
Neurofibromatosis-related tumors: emerging biology and therapies.
@ast
Neurofibromatosis-related tumors: emerging biology and therapies.
@en
prefLabel
Neurofibromatosis-related tumors: emerging biology and therapies.
@ast
Neurofibromatosis-related tumors: emerging biology and therapies.
@en
P2860
P1476
Neurofibromatosis-related tumors: emerging biology and therapies.
@en
P2093
Matthias A Karajannis
Rosalie E Ferner
P2860
P356
10.1097/MOP.0000000000000169
P577
2015-02-01T00:00:00Z